Kyoto, Japan

Tomomi Tanaka

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Ayumi Pharmaceutical Corporation. Active years: 2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tomomi Tanaka. Retrieved from https://idiyas.com/inventor/tomomi-tanaka-6qpqnft2

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0


Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2021

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Tomomi Tanaka

Introduction

Tomomi Tanaka is a notable inventor based in Kyoto, Japan. She has made significant contributions to the field of medicinal chemistry, particularly through her innovative work on BRD4 inhibitors. Her research has the potential to impact therapeutic approaches for various diseases.

Latest Patents

Tomomi Tanaka holds a patent for a compound known as 6H-thieno[2,3-e][1,2,4]triazolo[3,4-c][1,2,4]triazepine derivative. This invention demonstrates BRD4 inhibitory activity, making it useful as a medicament, especially as a prophylactic and therapeutic agent for diseases associated with BRD4.

Career Highlights

Tanaka is currently employed at Ayumi Pharmaceutical Corporation, where she continues to advance her research in pharmaceutical development. Her work is characterized by a commitment to innovation and the pursuit of effective medical solutions.

Collaborations

Some of her notable coworkers include Hiroyuki Aono and Iwao Seki, who contribute to her research endeavors and collaborative projects.

Conclusion

Tomomi Tanaka's contributions to medicinal chemistry and her innovative patent highlight her role as a significant inventor in the field. Her work continues to pave the way for advancements in therapeutic agents.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…